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Abstract: Tissue-engineered oral mucosal equivalents have been developed for in vitro studies for a few years now. However, the use-
fulness of currently available models is still limited by many factors, mainly the lack of a physiological extracellular matrix (ECM) and 
the use of cell populations that do not reflect the properly differentiated cytotypes of the mucosa of the oral cavity. For this reason, we 
have developed a novel three-dimensional culture model reflecting the normal architecture of the human oral mucosa, with the main aim 
of creating a better in vitro model where to test cellular responses to drugs administration. This novel 3D cell culture model (3D out-
growth) was set up using an artificial extracellular matrix (MatrigelTM), allowing the interactions required for proper differentiation of the 
various citotypes which form the mucosal layer. Biopsies of human oral mucosa, in fragments of about 0.5 mm3, were placed onto 6.5mm 
Transwells, covered with MatrigelTM and grown in a specific culture medium. A gradual formation of an architectural structure similar to 
that of the in vivo oral mucosa was observed. Transmission electron and confocal microscopy were employed to characterize the newly 
developed model: the cell components (keratinocytes and fibroblasts) differentiated properly within the outgrowth and reconstituted, in 
vitro, the physiological structure of the human oral mucosa, including a stratified non-keratinized squamous layer composed of four dif-
ferent layers, a proper basal membrane and a lamina propria where fibroblasts produce ECM. Moreover, keratinocytes expressed CK5, 
CK13, CK19 and E-cadherin, whereas fibroblasts expressed collagen type I and IV, laminin and fibronectin. 
3D outgrowths could be considered a valid alternative to animal models, and provide useful information for researchers interested in 
studying the responses of the human oral mucosa to locally delivered drugs or other exogenous treatments. 
Keywords: Tissue-engineering, human oral mucosa, 3D outgrowth model, keratinocytes, fibroblasts, transmission electron microscopy, im-
munofluorescence, immunogold. 
1. INTRODUCTION 
 Normal cells in the human body exist in a three-dimensional 
environment, completely surrounded by other cells, membranes, 
fibrous layers and adhesion proteins. But culturing cells on flat 
plastic flasks or plates results in artificial two-dimensional sheets of 
cells. Three-dimensional (3D) cultures mimic the in vivo cell envi-
ronment providing more physiologically significant information 
compared to in vitro cell culture models; however, there are several 
variables inherently associated with these assays that can influence 
the success of 3D cultures such as matrix composition, cell type, 
cell health, cell seeding densities, time of culture and basement 
membrane extract. The situation is further complicated when the 
creation of a 3D tissue equivalent containing different types of cells 
organized in a complex structure is attempted, entering in the ex-
perimental field of tissue engineering.  
 Tissue engineering has progressed greatly in the last twenty 
years or so, especially with regard to recreating function of specific 
tissues such as exocrine pancreas, cartilage, bone, skin and blood 
vessels. However, proper design models still need to be developed 
for engineering complex 3D ECM microenvironments to under-
stand disease progression. In fact, the main objectives of modern 
tissue engineering comprise repeating specific tissue functions for  
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regenerative medicine and developing in vitro models of human 
tissues to investigate disease pathogenesis, as well as for testing and 
screening new medications before expensive clinical trials. For 
these objectives to be successfully achieved, it is fundamental for 
the engineered models to recreate, in vitro, the complex in vivo 
interactions between cells and their microenvironments.  
 Tissue-engineered oral mucosal equivalents have been devel-
oped for in vitro biocompatibility studies, as well as for mucosal 
irritation and oral disease studies with the aim to better understand 
disease process and discover new treatments [1,2]. In the last dec-
ade, research has concentrated on the characterization of human 
mucosal equivalent by introducing new dermal scaffold and epithe-
lial cell culture methods. In 1975, Rheinwald and Green introduced 
a method to grow human keratinocytes in in vitro serial cultures, 
using a feeder layer composed of irradiated mouse fibroblasts and a 
specific culture medium [3]. This method is widely used for the 
culture of keratinocytes and single-layer epithelial sheets, but such 
sheets are fragile, difficult to handle and tend to contract [1]. Multi-
layer sheets of cultured epithelium were obtained by culturing oral 
keratinocytes and fibroblasts, crucial for the production of extracel-
lular matrix, on permeable ethylene terephthalate cell culture mem-
brane (PET) at the air/liquid interface [4] or in polycarbonate cell 
culture inserts, developed by SkinEthic Laboratories (Nice, France). 
These models have the characteristic of being very similar to native 
epithelium and showing signs of differentiation, such as different 
cytokeratin expression and basement membrane formation, but not 
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to the point of full differentiation because the cells used are derived 
from oral squamous carcinoma [1]. Moreover, the scaffold that 
supports the cells is an important element in oral mucosa recon-
struction. The currently available scaffolds can be divided into sev-
eral categories: naturally derived scaffolds, such as acellular dermis 
and amniotic membrane [5]; fibroblast-populated skin substitutes 
[6]; pure collagen scaffolds and collagen-based matrices [7]; gela-
tin-based scaffolds such as gelatin-hyaluronate and gelatin-
chitosan-hyaluronic acid; fibrin-based materials; synthetic scaf-
folds, such as elastin-like recombinant polymer [2] and hybrid scaf-
folds, which are combinations of natural and synthetic matrices [1]. 
The benefit of pure or collagen-based matrices is that the collagen 
gel supports fibroblasts, which provides a suitable substrate for 
keratinocyte multilayer formation, but it also biodegrades rapidly 
and has poor mechanical properties. However, the fibroblasts em-
bedded in the collagen gel have been shown to synthesize less ECM 
than those cultured on three-dimensional porous scaffolds. Potential 
weaknesses of artificial scaffolds include lack of porosity, poor 
fibroblast infiltration, and contraction of the scaffold when large 
numbers of fibroblasts are seeded [4]. Moreover, the incorporation 
of fibroblast-populated collagen into the pore of the scaffold is 
required to obtain better results [8]. Taking into account the notions 
discussed above, we have recently focused our research efforts on 
tissue-engineering a novel 3D model of the normal human oral 
mucosa, to overcome some of the shortcomings of the current in 
vitro models. Our model includes two cell populations (keratino-
cytes and fibroblasts) that outgrow from an oral biopsy fragment 
into a natural extracellular 3D matrix (Matrigel
TM
) that initially 
drives the outgrowth of the cells, and is completely replaced during 
the culture period by a newly deposed matrix produced by the fi-
broblasts. Matrigel
TM
 is a gelatinous protein mixture secreted by 
Engelbreth-Holm-Swarm (EHS) mouse sarcoma cells. This mixture 
resembles the complex extracellular environment found in many 
tissues and is considered to be a good cell culture substrate for its 
heterogeneous composition. The major components of Matrigel
TM
 
are basement membrane proteins such as laminin, entactin and 
collagen IV, which present cultured cells with the adhesive peptide 
sequences that they would encounter in their natural environment 
[19]. Matrigel
TM
 also contains growth factors that promote 
differentiation and proliferation of many cell types. Moreover, Ma-
trigel
TM
 constitutes a uniform and controllable structure, very im-
portant for accuracy and reproducibility of an in vitro model for 
compound testing use [4].  
 Our hypothesis was that this kind of model could exhibit a 
proper histological architecture and biochemical composition (two 
essential features required of an in vitro model that is to be em-
ployed to study the responses to exogenous modifications of its 
microenvironment, such as those that take place during drug ad-
ministration assays). In order to achieve this goal, we characterized 
the outgrowth model both at an ultra-structural and at an immuno-
phenotypic level. 
2. MATERIALS AND METHODS 
2.1. Materials 
2.1.1. Chemicals 
 HCl was purchased from Titolchimica (Pontecchio, Italy) and 
isopropanol from Carlo Erba (Milan, Italy). Glutaraldehyde, os-
mium tetroxide (OsO4), epoxy resin (Epon812) and epoxy accelera-
tor (DMP30) were purchased from Electron Microscopy Sciences 
(Hatfield, PA, USA). 1,2-Propylene oxide, NaH2PO4*2H2O, 
NaC6H5O7*H2O and NaOH were purchased from Merck (Darm-
stadt, Germany). UO2(CH3COO)22H2O and Pb(NO3)2 were pur-
chased from Sigma-Aldrich (Milan, Italy).  
 All chemicals and solvents were of analytical grade and were 
used without further purification. 
 
2.1.2. Cell Culture Reagents 
 Recombinant human EGF (hEGF) was purchased from Cell 
Signaling Technology (Beverly, MA, USA). L-Glutamine was ob-
tained from Stem Cell Technologies (Tukwila, WA, USA). Dul-
becco's Modified Eagle Medium (DMEM) was purchased from 
Sigma-Aldrich (Milan, Italy). GIBCO™ Keratinocyte-Serum Free 
Medium (Keratinocyte-SFM) was obtained from Invitrogen life 
technologies (Carlsbad, CA, USA). Fetal bovine Serum (FBS), 
Hanks BSS without phenol red (HBSS) and Phosphate Buffered 
Solution (PBS) were purchased from Lonza (Cologne, Germany).  
2.2. Methods 
2.2.1. Three-dimensional Oral Outgrowth Model 
 Human oral mucosa biopsies were obtained from patients re-
ferred to the Unit of Oral Medicine of the University of Palermo. 
The following procedures were adopted, conforming to the relevant 
ethical guidelines for human research and in agreement with the 
Helsinki Declaration of 1975 as revised in 1983, as well as ap-
proved by the Ethic Council of the Polyclinic of the University of 
Palermo, Italy. Written informed consents were obtained from all 
patients. Each patient was subjected to topical antifungal therapy 
(miconazole 2% oral gel, Daktarin, Janssen-Cilag) 3 times/day for 
seven days before the biopsy. After a 1 minute oral rinse with 0.2% 
chlorhexidine, oral mucosa samples were obtained by a 6 mm di-
ameter biopsy punch on the margin of the lesion with clinically 
healthy tissue. Each sample was divided into two parts. The outer 
part of the sample was fixed in formalin and sent for histo-
citopathological examination, while the inner part was immediately 
placed in fresh culture medium and processed for the 3D oral out-
growths. A total of six subjects, whose histo-citopathological ex-
amination resulted negative for dysplastic/cancerous lesions of the 
oral cavity, were recruited for this study. 
 Biopsies were washed several times in PBS, subsequently cut 
into 0.5 mm
3
 pieces using a sterile scalpel, and placed in the middle 
of 6.5 mm Transwells on a nylon membrane (Becton Dickinson, 
Franklin Lakes, NJ, USA) and embedded in 60 l of MatrigelTM 
(Becton Dickinson). The Transwells were placed on 24 well culture 
plates (Corning Life Sciences), and these were then kept at 37°C for 
5 minutes to facilitate Matrigel
TM
 jellification. 330 l of growth 
medium mix was then added to each well. This mix was constituted 
of Keratinocyte-SFM supplemented with 5ng/ml of h-EGF and 
DMEM supplemented with 10% FBS (1: 1), which was placed 
underneath the nylon membrane of the Transwells. The outgrowths 
were cultured at 37°C in a 5% CO2 atmosphere and the medium 
was changed every 48 hours. An inverted light microscope 
equipped with phase contrast rings (LEICA DM-IRB, Leica Micro-
systems Srl, Milan, Italy) was used to monitor the outgrowths. After 
15 days in culture the outgrowths were prepared for electron mi-
croscopy and immunostaining as described below. By this time 
point, the has been completely dissolved by the proteolytic activity 
of the cells and therefore there is no need to separate the outgrowths 
from the Matrigel
TM
. 
2.2.2. Electron Microscopy  
 Immediately after excision of the nylon membrane from the 
Transwells using a scalpel, the outgrowths were fixed in a 2.5% 
glutaraldehyde solution in phosphate buffer, pH 7.4, for 20 minutes 
at room temperature. Phosphate-buffered saline (PBS) Ca
2+
 and 
Mg
2+-
free solution (pH 7.4) was prepared by dissolving KH2PO4 
(0.144 g), anhydrous Na2HPO4 (0.795 g) and NaCl (9.0 g) in 1 litre 
of distilled water. After fixation, the glutaraldehyde was removed 
and the outgrowths were stored in Millonig’s Buffer. 25,6g of 
NaH2PO4 x 2H2O was added to 1 litre of distilled water to make the 
A solution of Millonig’s Buffer. To obtain the B solution, 25,2g of 
NaOH was added in 1 litre of distilled water. Finally, 83 ml of the 
A solution was mixed with 17ml of the B solution to make 100ml 
of Buffer; the pH was adjusted to 7.4. After 3 consecutive washes 
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in Millonig’s Buffer, the pieces were post-fixed in 1% OsO4 for 2 h, 
dehydrated in an ascending ethanol series, treated for 30’ in propyl-
ene oxide, infiltrated with epoxy resin (Epon812, Electron Micros-
copy Science, Hatfield, PA, USA) in propylene oxide (1: 3, 1: 2, 1: 
1 for 30 minutes at room temperature respectively), and finally 
embedded in Epon812 with DMP30. The resin was then polymer-
ized at 60°C for 48 hours. Ultrathin and semithin sections were cut 
with an ultramicrotome (Ultracut E, Reichert-Jung, Depew, NY, 
USA) at different thicknesses and mounted on copper and gold 
grids or on glass slides for further use. Contrast solution for the 
grids to be used for electron microscopy was prepared by dissolving 
0,7g of uranyl acetate in 10ml of methanol; Reynolds’ solution was 
prepared by dissolving 1,33g of Pb(NO3)2 and 1,76g NaC6H5O7 x 
H2O and 8ml of NaOH 1N in 50 ml of distilled water at pH 12. 
2.2.3. Indirect Immunofluorescence 
 3D outgrowths were stained in situ at the appropriate time 
points. Briefly, outgrowths were washed once with 1ml/well of 
HBSS and fixed in situ in 500l/well of ice-cold absolute methanol 
for 20 minutes at –20°C. Outgrowths, inside their plastic supports, 
were then left to dry in a laminar flow cabinet for 30 minutes and 
stored at –20°C. Trays were defrosted at room temperature, and 
washed twice with 1ml/well of phosphate buffered saline (PBS), 
permeabilized with 500l/well of Triton X-100 (Sigma, UK) 0.1% 
in PBS for 3 minutes on ice and washed once with 1ml/well of 
PBS. Unspecific binding sites were blocked with 250l/well of 
DMEM 10% FBS for 15 minutes. During this period, the primary 
antibodies were diluted in incubation buffer (DMEM 10%, Tween-
20 0.1% and Sodium Azide 0.1% in PBS). The blocking buffer was 
then removed, and without washing, the diluted antibodies were 
added to the wells for 45 minutes. Wells were then washed twice 
with 1ml/well of incubation buffer and, when needed, secondary 
antibodies were diluted in incubation buffer and applied to the wells 
for 45 minutes. Secondary antibodies were conjugated with differ-
ent fluorochromes.  
 Table 1 shows a list of all the primary antibodies employed and 
their working dilutions. 
 The secondary antibodies were: a secondary Alexa Fluor647–
conjugated goat anti-rabbit Ab (1: 500; Molecular Probes, USA); a 
secondary FITC-conjugated goat anti-mouse IgG Ab (working dilu-
tion 1: 400, purchased from Sigma, UK); a secondary TRITC-
conjugated goat anti-mouse IgG Ab (working dilution 1: 500, pur-
chased from Sigma, UK). At the end of the 45 minutes incubation 
with the secondary antibodies, wells were washed twice with 1 ml 
of PBS and coverslips mounted with MOVIOL (DABCO) mount-
ing medium. Appropriate negative controls were prepared by re-
placing primary antibodies with proper isotype control sera. 
 The trays were then ready to be observed with a LEICA SP5 
inverted confocal microscope (Leica, Heidelberg, Germany) with 
filters for FITC (excitation 488 nm, emission 500–535 nm), TRITC 
(excitation 557 nm, emission 560–600 nm), and Alexa Fluor647 
(excitation 633 nm, emission 640–680 nm). Each image was aver-
aged from 14 scans within a thickness of 5 to 7 μm. 
Table 1. List of primary antibodies used for immunostaining with their supplier, clone name, source and final dilution. In brackets is 
reported the dilution that was used for Immunogold. 
 Supplier Clone Source Dilution 
CK1 Santa Cruz, UK 4d12b3 Mouse IgG1 1: 100 
CK5 “ H-40 Rabbit IgG 1: 600 
CK10 “ AE20 Mouse IgG1 1: 50 
CK13 Abnova, USA 1C7 Mouse IgG2a 1: 200 
CK19 Santa Cruz, UK BA17 Mouse IgG1 1: 200 
CK20 “ E-9 Mouse IgG1 1: 100 
Collagen type I Millipore, UK 5D8-G9 Mouse IgG1 1: 50 
Collagen type IV Santa Cruz, UK Col-94 Mouse IgG1 1: 200 
Laminin Millipore, UK 2G6/A2 Mouse IgG1 1: 200 
E-cadherin Santa Cruz, UK G-10 Mouse IgG1 1: 50 
Fibronectin Abnova, USA 568 Mouse IgG1 1: 30 
Involucrin “ m-116 Rabbit IgG 1: 400 
MITF “ H-50 Rabbit IgG 1: 500 
CD3 R&D Systems, USA UCHT1 Mouse IgG1 1: 100 
CD4 “ 34930 Mouse IgG1 1: 50 
CD8 “ 37006 Mouse IgG2b 1: 50 
CD45 “ 2D1 Mouse IgG1 1: 100 
CD68 “ 298807 Mouse IgG2b 1: 100 
MPO “ 392105 Mouse IgG2b 1: 50 
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 Immunofluorescent staining was semi-quantified by scoring the 
percentage of positive cells or area (depending on the antigen of 
interest), evaluated by three different operators (AMG, AF and AP) 
in five different mid-magnification (400x) microscopic fields 
(score: - absence of immunostaining, -/+ less than 10% of the total 
number of cells/area scored positively; + between 10% and 50% 
scored positively; ++ 50-100% of the total number of cells/area 
were positive). 
2.2.4. Immunogold 
 Ultrathin sections were mounted on gold grids to prepare them 
for the immunogold assay. The outgrowths were included in epoxy 
resin that notoriously covers antigenic sites, making the execution 
of immunological investigation techniques considerably more diffi-
cult. A pre-treatment to unmask the sites with sodium citrate was 
performed to ensure better results. Gold grids were placed in a 
baker filled with a sodium citrate solution and subsequently micro-
waved for 4 minutes at 850W. 
 The grids were then washed twice in PBS, and subsequently 
incubated in a serum blocking solution for 30 minutes and, without 
washing, the incubation proceeded with primary antibodies diluted 
in dilution buffer for 1 hour and half at room temperature. Primary 
antibodies used were against laminin, fibronectin and collagen type 
IV and their dilutions can be found in Table 1. Appropriate negative 
controls were prepared by replacing primary antibodies with proper 
isotype control sera.Grids were rinsed five times with PBS for 3 
min and incubated with secondary antibody conjugated with 10nm 
colloidal gold particles for 30 minutes at room temperature, and 
washed again for five times with PBS for 3 min. The grids were 
then fixed in a 2.5% glutaraldehyde solution in PBS for 15 minutes 
and finally washed five times in distilled water for 3 minutes. The 
grids were then prepared for contrast staining by treating them with 
uranyl acetate for 5 minutes, followed by eight washes with metha-
nol for 2 minutes, treated with Reynolds’ solution for 5 minutes and 
finally rinsed eight times in distilled water for 2 minutes. After this 
procedure, the grids were ready for electron microscopy. 
3. RESULTS 
3.1. Morphological Observation of the 3D Outgrowths 
 (Fig. 1) shows the evolution of a 3D human oral mucosa out-
growth during its first fifteen days in culture. Phase contrast mi-
croscopy (PhaCo) revealed that the 3D outgrowths initially formed 
a network of spindly cells (likely fibroblasts) and rounded cells 
(possibly epithelial cells), only visible at higher magnifications, 
growing out into the Matrigel
TM
 from the biopsy which was origi-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Phase contrast observation of a 3D human oral mucosa outgrowth during its first 15 days in culture. During the first stages, mesenchymal cells 
emerge from the biopsy fragment, followed by epithelial cells. After around 7 days of culture, the cells have covered all the nylon membrane of the insert. 
Subsequently, the growth becomes three-dimensional. Bar = 2mm. 
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nally placed in the middle of the transwell system (Fig. 1, day 5). 
After 7 days, the nylon membrane covering the bottom of the insert 
was completely covered with the newly grown tissue, and starting 
to develop three-dimensionally forming ridges and more complex 
3D structures. After 13-15 days of culture, the morphological fea-
tures of the outgrowths (as observed with the PhaCo) did not dis-
play any further significant changes. In our experience, unless spe-
cific damaging events (e.g. contamination with infectious organ-
isms) occur during the culture period, and providing proper culture 
conditions are maintained, it is possible to continue to grow these 
3D cultures for a period of up to two months. 
3.2. Transmission Electron Microscopy Characterization of the 
3D Outgrowths 
 In order to evaluate the ultra-structural features of our 3D hu-
man oral mucosa outgrowths, these were grown until differentiation 
was complete (around 14 days in most cases) and then prepared for 
TEM analysis as detailed in section 2.2.2.  
 (Fig 2) shows typical TEM micrographs obtained from a sam-
ple that was grown for 15 days. TEM analysis enabled us to identify 
in the outgrowths two different cell populations, non-keratinized 
epithelial cells above and fibroblasts underneath. The epithelial 
layer was composed of different strata, reminiscent of the basal, 
spinous, intermediate and superficial layers of the human oral mu-
cosa in vivo. (Fig. 2A) is a low magnification view of the outgrowth 
that shows, in particular, the lowest three strata of the epithelial 
layer. The epithelial cells exhibit a squamous non-keratinized phe-
notype, typical of the oral lining mucosa, and as better illustrated 
with a higher magnification in (Fig. 2B), epithelial interactions are 
guaranteed by tight junction devices (desmosomes, white arrows). 
(Fig. 2C) shows a particular of the fibroblast layer (lamina propria) 
that displays the characteristic spindly morphology of these cells 
and also the presence of an abundant extracellular matrix; note that 
it was not possible to discriminate between the papillary and reticu-
lar layer in this region, suggesting that mechanical forces, clearly 
not present in this model, could be responsible for the development 
of these two layers in vivo. (Fig. 3A) shows a highly magnified 
region of the interface between the basal and spinous layers, with 
the two adjacent cytoplasmic membranes of two keratinocytes 
tightly held together by a desmosome (white arrows) with both the 
attachment plaques well evident, together with the intermediate 
filaments starting from them. In this region, it is also interesting to 
note tightly packed cytokeratin filaments (tonofibrils, white arrow-
heads) interacting with the desmosomal structure; this is a typical 
morphological feature of the cytoskeleton of the basal keratinocytes 
of human oral mucosa. In (Fig. 3B) it is possible to observe that the 
basal epithelial cells are separated from the underlying fibroblast 
layer by a properly constituted basal membrane with which they 
both interact through hemidesmosomes (white arrows); in this mi-
crograph it is only possible to observe the two most superficial 
regions of the basal membrane, the lamina lucida and densa, be-
cause the innermost one, the lamina reticularis, is lost during the 
fixation procedure that unfortunately determines a detachment of 
the epithelial layers from the fibroblastic one. (Fig. 3C) shows de-
tails of a cytoplasmic process of a fibroblast: it is quite clear that the 
proteic material (white arrows) that will eventually form the ECM 
is extruded into the extracellular space from caveolae-like struc-
tures (white arrowhead) present on the cytoplasmic membrane of 
the fibroblasts. This proteic material is mainly constituted by colla-
gen proteins, as shown in (Fig. 3D).  
 Both the epithelial and fibroblast layers in this model are avas-
cular.  
 Moreover, it was not possible to identify any other cytotypes 
(such as immune cells or melanocytes) apart from the ones already 
described. This characteristic is another benefit of our model, be-
cause it enables the study of cellular processes devoid of the pres-
ence of inflammatory cells and their products. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). TEM observation of a 3D outgrowth after 15 days in culture. In 
(A) is shown the epithelial layer with its basal, spinous and intermediate 
layers. (B) is a higher magnification of the interface between the basal and 
spinous layers of the epithelial layer. In (C) is shown the fibroblast layer 
(lamina propria) where fibroblasts are surrounded by ECM proteins. Bars in 
A and C = 10 m, bar in B = 400nm 
3.3. Immunophenotipical Characterization 
3.3.1. Immunofluorescence 
 In order to properly characterize our 3D outgrowths, these were 
stained with a panel of antibodies directed towards some of the 
most common markers of the human oral mucosa components, and 
visualized by laser confocal microscopy in order to perform precise 
scans at the desired level of the different strata composing the  
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outgrowth. A complete list of all the antibodies employed can be 
found in Table 1.  
 (Fig. 4) shows four of the markers that were used to differenti-
ate between the cell populations: CK5 and CK13 were employed to 
characterize basal and differentiated keratinocytes respectively (Fig. 
4A and B), whereas laminin (Fig. 4C) and collagen type IV (Fig 
.4D) were used, together with fibronectin and collagen type I (not 
shown), to study the ECM. CK5 staining was limited to the basal 
layer and positive cells had a distinctive rounded shape (Fig. 4A) 
whereas CK13 staining, that was present throughout the whole 
epithelial stratum, was much stronger in the upper layers and posi-
tive cells had a typical squamous shape (Fig. 4B).  
 Table 2 shows the scores obtained with our panel of antibodies 
in 3D outgrowths from six different subjects (#1 to #6). These data 
are compatible with a properly organized and differentiated normal 
oral mucosa. However, it is interesting to note that in our model 
Merkel cells (as identified by CK20), melanocytes (MTIF) and 
immune/inflammatory cells (CD3, CD4, CD8, CD45, CD68 and 
MPO) were completely absent.  
3.3.2. Immunogold. 
 In order to verify whether the ECM proteins that were found in 
the lamina propria of our 3D outgrowths with the immunofluores-
cent staining, had effectively been produced by the resident fibro-
blasts, these proteins were precisely localized inside the fibroblasts 
cytoplasm by TEM immunogold assay. (Fig. 5) shows representa-
tive micrographs of immunogold staining of fibroblasts of the lam-
ina propria of the 3D outgrowth, with antibodies directed towards 
laminin (Fig. 5A), fibronectin (Fig. 5B) and collagen type IV (Fig. 
5C). All proteins analyzed were found to be expressed in the cyto-
plasm of the fibroblasts, especially in the proximity of and within 
vacuolar cytoplasmic structures, with the exception of collagen type 
IV whose staining was diffuse. 
4. DISCUSSION 
 Various cell-secreted macromolecular components make up the 
intricate, highly hydrated polymer gel that constitutes the three-
dimensional extracellular microenvironment. The ECM is com-
posed of cross-linked, physically immobilized sugar and protein 
elements. Further components include growth factors, chemokines, 
cytokines and other soluble effectors with important signaling func-
tions, as well as membrane-anchored molecules, donated by neigh-
boring cells, that have the crucial task of enabling cell-cell commu-
nication in tissue morphogenesis. Fibrous proteins, such as elastin, 
fibronectin, laminins and collagens, and hydrophilic proteoglycans 
containing large glycosaminoglycan side chains, such as hyaluronic 
acid, are two of the principal ECM macromolecules. While these 
components are present in the majority of ECMs, their form and 
organization, as well as their biochemical and mechanical proper-
ties diverge considerably between different types of tissues. In addi-
tion to its basic functions as a solid support structure upon which 
cells are organized into 3D tissues, or simply as a physical bound-
ary between neighboring tissues, ECM also regulates multiple 
morphogenesis-driving cellular processes, such as cell adhesion, 
migration, proliferation and division, via distinct receptor-ligand 
interactions [14, 15].  
 Notable progress has been made in the last decade or so in de-
vising artificial ECMs. Suitable materials for productive use in 
three-dimensional cell cultures and in vivo tissue regeneration have 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). High magnification TEM analysis of keratinocytes and fibroblasts in a 15 days old 3D outgrowth. (A) shows a highly magnified region of the 
interface between the basal and spinous layers, displaying the two adjacent cytoplasmic membranes of two keratinocytes held tightly together by a desmosome 
(white arrows) from which tonofibrils (white arrowheads) project into the cytoplasm; (B) shows the basal epithelial cells, separated from the underlying fibro-
blasts layer by a properly constituted basal membrane with which they both interact through hemidesmosomes (white arrows); (C) shows details of a fibroblast 
surrounded by ECM proteins. The cytoplasm of the fibroblasts contain vacuoles filled with proteic material and their cytoplasmic membranes present caveo-
lae-like structures (white arrowhead), from where the assembled proteins (white arrows) are released into the extracellular space. This proteic material is 
mainly constituted by collagen proteins, as shown in (D). Bars in A, B and C = 200nm, in D = 50nm. 
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Fig. (4). Immunofluorescence staining of the epithelial (A and B) and fibroblast (C and D) layers in a 15 days old 3D outgrowth. The basal keratinocytes 
resulted positive for CK5 (A), whereas the more differentiated ones resulted positive for CK 13 (B); the fibroblast layer was positive for laminin (C) and colla-
gen type IV (D). E shows a negative isotype control. Bar = 40m. 
 
Table 2. Semi-quantification of the immunophenotypic analysis of the markers studied. 3D outgrowths from six different subjects were 
stained with several markers whose expressions were semi-quantified with the following scoring system: (-) absence of immu-
nostaining, (-/+) less than 10% of the total number of cells/area scored positively; (+) between 10% and 50% scored positively; (++) 
50-100% of the total number of cells/area were positive. 
 #1 #2 #3 #4 #5 #6 
CK1 - - - - - -/+ 
CK5 ++ + ++ ++ ++ ++ 
CK10 - - - -/+ - - 
CK13 ++ ++ ++ ++ ++ ++ 
CK19 -/+ -/+ + -/+ - -/+ 
CK20 - - - - - - 
Collagen I ++ ++ ++ ++ ++ + 
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(Table 2) Contd.... 
 
 #1 #2 #3 #4 #5 #6 
Collagen IV + + + + + + 
Laminin + + + -/+ + + 
Fibronectin + + ++ + + + 
E-cadherin ++ ++ ++ + ++ ++ 
Involucrin + -/+ - -/+ - -/+ 
MITF - - - - - - 
CD3 - - - - - - 
CD4 - - - - - - 
CD8 - - - - - - 
CD45 - - - - - - 
CD68 -/+ - - -/+ - - 
MPO - - - - -/+ - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (5). Immunogold staining of fibroblast cytoplasmic proteins. A 15 days old 3D outgrowth of human oral mucosa was immunostained for laminin (A), 
fibronectin (B) and collagen type IV (C) using secondary antibodies labelled with colloidal gold particles 10nm in diameter and then analysed by TEM. D 
shows a negative isotype control. Bar = 50nm. 
 
become a reality thanks to the application of biological recognition 
principles. Nonetheless, these artificial systems can still only reiter-
ate a small portion of the key signaling and cell response functions 
of natural ECMs, with a few characteristic functions remaining 
beyond the grasp of the synthetic versions at the moment. These 
include the near-physiological multifunctional capabilities of the 
ECM; while most artificial ECMs utilize two classes of bio-
molecules, the natural ones are comprised of various different bio-
chemical cues. Additionally, artificial ECMs lack in the temporal 
complexity in signal presentation, with the time frames and dynam-
ics being fairly restricted in terms of longevity and complexity. 
Spatial complexity represents a further shortcoming of artificial 
ECMs. Matrix-immobilized 3D morphogen gradients are an essen-
tial factor in tissue development and regeneration, enabling several 
cell types and patterns to be spatially generated in relation to the 
original signal source, as well as controlling the migration of spe-
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cific cells to specific locations. Although biomolecule gradients 
have been created using hydrogel surfaces [16, 17], to date no one 
has succeeded in recreating them in artificial cell-responsive 3D 
ECMs. The versatility of artificial ECMs is also hindered by the 
absence of a suitable feedback system to control cell-matrix interac-
tions. Characteristic of natural ECMs, these include features such as 
proteases capable of cleaving ECM components, generating cleav-
age products that can have important signaling functions [18]. 
Moreover, most artificial ECMs currently available have some cell-
specificity issues, since protease substrates of cell-responsive ma-
trices consist of short, linear peptides with limited specificity for 
particular proteases; this is not the case in matrices composed of 
natural proteins. Therefore, most artificial ECMs are not specific to 
particular cells or their protease secretions, respectively. Another 
important factor that must be considered in oral mucosa model 
reconstruction is the type and origin of fibroblasts and keratino-
cytes. Fibroblasts are usually isolated from the dermal layer of the 
skin or obtained by oral mucosal biopsy, and used for tissue engi-
neering at early passages, because their ECM production decreases 
as the passage number increases [1]. Keratinocytes can be obtained 
from different sites of the oral cavity, such as the hard palate [9], 
gingiva [10] or buccal mucosa [11]. Normal human keratinocytes 
should also be used at very early passages, but immortalized human 
keratinocytes, such as HaCaT cells [12] or TR146 cells [13], can be 
used at extended passages in the reconstruction of oral mucosal test 
models. However, epidermal differentiation of transformed kerati-
nocytes is not perfect, and tumor derived cells are abnormal and not 
suitable for clinical use [1]. The results that we obtained during the 
development and characterization of our 3D model of the human 
oral mucosa clearly show that this system is a very good candidate 
for tissue-engineering the normal human oral mucosa. In our model, 
oral biopsies are placed directly on Matrigel
TM
 in Transwells 
equipped with a nylon membrane necessary to allow the passage of 
culture medium. Cells from our 3D outgrowth find in the Ma-
trigel
TM
 all the factors necessary to develop and to reconstitute the 
structures of the original tissue. However, after this initial phase, 
cells within the outgrowth start to demolish the Matrigel
TM
 and 
begin to lay down their own ECM. This is a crucial moment in the 
development of the 3D outgrowth, resulting in a proper differentia-
tion of the cell components (keratinocytes and fibroblasts) and in an 
in vitro reconstitution of the physiological architecture of human 
oral mucosa, including a stratified non-keratinized squamous layer 
composed of several layers, a proper basal membrane and a lamina 
propria where fibroblasts continue to produce ECM and biochemi-
cally signal with the layers above.  
 Melanocytes, Merkel cells and immune cells are not present in 
our 3D outgrowth model. As stated earlier, this is not necessarily a 
negative aspect, as it in fact enables us to study the eventual re-
sponses of the oral mucosa to exogenous molecules (such as drugs, 
growth factors, cytokines etc.) in the absence of confounding fac-
tors and signals produced by the immune cells, thus rendering this 
model a valid tool for studying, for example, the effectiveness of 
drugs administration.  
 Even if Matrigel
TM
 is considered one of the most effective sub-
strates for 3D cell culture, we believe that the strength of our out-
growth model is not so much in the culture medium used or in the 
matrix, but in the common source of fibroblasts and keratinocytes. 
In fact, fibroblasts and keratinocytes of our model are not separately 
isolated from the dermal layer or buccal mucosa respectively, and 
combined again in a scaffold of different materials, but they origi-
nate from the same biopsy. In this manner, the cultured tissue main-
tains the distinct characteristics of the single original source.  
5. CONCLUSIONS 
 Primary cultures or cell lines still represent the most commonly 
used human in vitro culture models to study responses of cell sys-
tems to specific stimuli. However, the main limitations of these 
models are the absence of extracellular components and the loss of 
proper cell-cell communication that arises from the former charac-
teristic. In our model, both keratinocytes and fibroblasts outgrow 
autonomously from an oral biopsy into a 3D gel (Matrigel
TM
), 
whose composition is very similar to that of the normal ECM of the 
oral mucosa. Moreover, after the initial expansion phase, fibroblasts 
start to lay out a newly formed ECM that is architecturally and 
structurally compatible with that of the in vivo human oral mucosa. 
In the meantime, the keratinocytes start differentiating because of 
the air-liquid interface, and after around 15 days of culture the out-
growths present a properly differentiated oral epithelium separated, 
by a functional basal membrane, from a newly constituted lamina 
propria where fibroblasts lay the ECM. In our opinion, this consti-
tutes a valid model where to study the responses of the human oral 
mucosa as a whole, to the administration of drugs and other exoge-
nous substances. 
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